Baker & McKenzie LLP
03/05/2026 | Press release | Distributed by Public on 03/05/2026 04:59
Baker McKenzie Advises Citibank- and UBS-Led Bank Syndicate on USD 1 Billion Financing for Galderma
Baker McKenzie advised a syndicate consisting of 12 international banks on a USD 1 billion multicurrency revolving credit facility agreement for Galderma Holding AG. Citibank, N.A., London Branch and UBS Switzerland AG acted as coordinators, bookrunners and mandated lead arrangers. UBS Switzerland AG acted as facility agent.
Galderma (SIX: GALD) is a pure-play dermatology category specialist, present in approximately 90 countries. It delivers a portfolio of premium flagship brands and services that span the full spectrum of the dermatology market through injectable aesthetics, dermatological skincare and therapeutic dermatology.
Baker McKenzie advised the lenders on all legal and tax aspects of the transaction. The team was led by Markus Wolf (Banking and Finance, Zurich) and included Andrea Bolliger (Tax, Zurich).
Galderma (SIX: GALD) is a pure-play dermatology category specialist, present in approximately 90 countries. It delivers a portfolio of premium flagship brands and services that span the full spectrum of the dermatology market through injectable aesthetics, dermatological skincare and therapeutic dermatology.
Baker McKenzie advised the lenders on all legal and tax aspects of the transaction. The team was led by Markus Wolf (Banking and Finance, Zurich) and included Andrea Bolliger (Tax, Zurich).
Baker & McKenzie LLP published this content on March 05, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 05, 2026 at 10:59 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]